nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Lipase increased—Mesalazine—Crohn's disease	0.0158	0.0888	CcSEcCtD
Pasireotide—Adrenal insufficiency—Prednisone—Crohn's disease	0.0117	0.0659	CcSEcCtD
Pasireotide—Octreotide—MPO—Crohn's disease	0.0106	0.748	CrCbGaD
Pasireotide—Amylase increased—Mesalazine—Crohn's disease	0.00975	0.0548	CcSEcCtD
Pasireotide—Cholelithiasis—Mesalazine—Crohn's disease	0.00747	0.042	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.00564	0.0317	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—MLN—Crohn's disease	0.00452	0.0056	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00447	0.00553	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00446	0.00552	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.0044	0.00545	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—CCR6—Crohn's disease	0.00437	0.00541	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00419	0.00518	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00415	0.00513	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00412	0.00509	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00406	0.00503	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00405	0.00502	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CCR9—Crohn's disease	0.00399	0.00494	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00389	0.00481	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CCR9—Crohn's disease	0.00383	0.00474	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00383	0.00474	CbGpPWpGaD
Pasireotide—Alopecia—Mercaptopurine—Crohn's disease	0.0038	0.0213	CcSEcCtD
Pasireotide—SSTR5—G alpha (i) signalling events—CCR6—Crohn's disease	0.00372	0.0046	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—GPR65—Crohn's disease	0.00371	0.0046	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00357	0.00442	CbGpPWpGaD
Pasireotide—Desmopressin—PTGS2—Crohn's disease	0.00357	0.252	CrCbGaD
Pasireotide—SSTR1—GPCR ligand binding—GPR65—Crohn's disease	0.00356	0.00441	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00347	0.0043	CbGpPWpGaD
Pasireotide—Anaemia—Mercaptopurine—Crohn's disease	0.00346	0.0194	CcSEcCtD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00345	0.00427	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—CCR6—Crohn's disease	0.00343	0.00424	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00343	0.00424	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00342	0.00424	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CCR9—Crohn's disease	0.0034	0.0042	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00333	0.00412	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—MLN—Crohn's disease	0.00326	0.00403	CbGpPWpGaD
Pasireotide—Arthralgia—Mercaptopurine—Crohn's disease	0.00318	0.0179	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00318	0.00394	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—GPR65—Crohn's disease	0.00316	0.00391	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CCR9—Crohn's disease	0.00313	0.00388	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—MLN—Crohn's disease	0.00312	0.00386	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—ACKR2—Crohn's disease	0.00312	0.00386	CbGpPWpGaD
Pasireotide—Dry skin—Mesalazine—Crohn's disease	0.00309	0.0174	CcSEcCtD
Pasireotide—Abdominal pain upper—Mesalazine—Crohn's disease	0.00308	0.0173	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00306	0.00379	CbGpPWpGaD
Pasireotide—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00304	0.0171	CcSEcCtD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00304	0.00376	CbGpPWpGaD
Pasireotide—Nasopharyngitis—Mesalazine—Crohn's disease	0.00301	0.0169	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—ACKR2—Crohn's disease	0.00299	0.0037	CbGpPWpGaD
Pasireotide—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00297	0.0167	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—MLN—Crohn's disease	0.00296	0.00366	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00295	0.00366	CbGpPWpGaD
Pasireotide—Abdominal distension—Mesalazine—Crohn's disease	0.00293	0.0165	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00293	0.00363	CbGpPWpGaD
Pasireotide—Influenza—Mesalazine—Crohn's disease	0.00291	0.0164	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—GPR65—Crohn's disease	0.00291	0.00361	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MLN—Crohn's disease	0.00283	0.00351	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.0028	0.00347	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.0028	0.00347	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00278	0.0156	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—MLN—Crohn's disease	0.00277	0.00343	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00273	0.00337	CbGpPWpGaD
Pasireotide—Decreased appetite—Mercaptopurine—Crohn's disease	0.00265	0.0149	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—ACKR2—Crohn's disease	0.00265	0.00328	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CCR6—Crohn's disease	0.00265	0.00327	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0026	0.00322	CbGpPWpGaD
Pasireotide—Hypercholesterolaemia—Prednisone—Crohn's disease	0.0026	0.0146	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—MLN—Crohn's disease	0.00255	0.00316	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CCR6—Crohn's disease	0.00254	0.00314	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MLN—Crohn's disease	0.00251	0.00311	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—ACKR2—Crohn's disease	0.00245	0.00303	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0024	0.00297	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—PTGER4—Crohn's disease	0.00233	0.00288	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MLN—Crohn's disease	0.00232	0.00287	CbGpPWpGaD
Pasireotide—Oedema peripheral—Mesalazine—Crohn's disease	0.0023	0.0129	CcSEcCtD
Pasireotide—Alopecia—Azathioprine—Crohn's disease	0.00226	0.0127	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—CCR9—Crohn's disease	0.00226	0.00279	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CCR6—Crohn's disease	0.00225	0.00278	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—PTGER4—Crohn's disease	0.00223	0.00276	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CCR9—Crohn's disease	0.00216	0.00268	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—GPR65—Crohn's disease	0.0021	0.0026	CbGpPWpGaD
Pasireotide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00209	0.0117	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—CCR6—Crohn's disease	0.00208	0.00257	CbGpPWpGaD
Pasireotide—Alopecia—Mesalazine—Crohn's disease	0.00206	0.0116	CcSEcCtD
Pasireotide—Anaemia—Azathioprine—Crohn's disease	0.00206	0.0116	CcSEcCtD
Pasireotide—Diabetes mellitus—Prednisone—Crohn's disease	0.00205	0.0115	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CCR9—Crohn's disease	0.00205	0.00254	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—GPR65—Crohn's disease	0.00201	0.00249	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—PTGER4—Crohn's disease	0.00198	0.00245	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCR9—Crohn's disease	0.00196	0.00243	CbGpPWpGaD
Pasireotide—Back pain—Mesalazine—Crohn's disease	0.00196	0.011	CcSEcCtD
Pasireotide—Vomiting—Mercaptopurine—Crohn's disease	0.00194	0.0109	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CCR9—Crohn's disease	0.00192	0.00238	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—GPR65—Crohn's disease	0.00191	0.00236	CbGpPWpGaD
Pasireotide—Myalgia—Azathioprine—Crohn's disease	0.0019	0.0107	CcSEcCtD
Pasireotide—Arthralgia—Azathioprine—Crohn's disease	0.0019	0.0107	CcSEcCtD
Pasireotide—Anaemia—Mesalazine—Crohn's disease	0.00188	0.0105	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00187	0.00232	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ACKR2—Crohn's disease	0.00184	0.00228	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—PTGER4—Crohn's disease	0.00183	0.00226	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—GPR65—Crohn's disease	0.00183	0.00226	CbGpPWpGaD
Pasireotide—Vertigo—Mesalazine—Crohn's disease	0.00182	0.0103	CcSEcCtD
Pasireotide—Nausea—Mercaptopurine—Crohn's disease	0.00181	0.0102	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.0018	0.00222	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—GPR65—Crohn's disease	0.00178	0.00221	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CCR9—Crohn's disease	0.00177	0.00219	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ACKR2—Crohn's disease	0.00177	0.00219	CbGpPWpGaD
Pasireotide—Hypertension—Mesalazine—Crohn's disease	0.00175	0.00985	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—MLN—Crohn's disease	0.00175	0.00216	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCR9—Crohn's disease	0.00174	0.00216	CbGpPWpGaD
Pasireotide—Myalgia—Mesalazine—Crohn's disease	0.00173	0.00971	CcSEcCtD
Pasireotide—Arthralgia—Mesalazine—Crohn's disease	0.00173	0.00971	CcSEcCtD
Pasireotide—Anxiety—Mesalazine—Crohn's disease	0.00172	0.00968	CcSEcCtD
Pasireotide—Hypotension—Azathioprine—Crohn's disease	0.0017	0.00955	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—MLN—Crohn's disease	0.00167	0.00207	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00167	0.00207	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00166	0.00931	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—GPR65—Crohn's disease	0.00165	0.00204	CbGpPWpGaD
Pasireotide—Dry skin—Prednisone—Crohn's disease	0.00163	0.00919	CcSEcCtD
Pasireotide—Hypokalaemia—Prednisone—Crohn's disease	0.00162	0.00912	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—GPR65—Crohn's disease	0.00162	0.00201	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCR9—Crohn's disease	0.00161	0.00199	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.0016	0.00198	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TAGAP—Crohn's disease	0.0016	0.00198	CbGpPWpGaD
Pasireotide—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00157	0.00884	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—ACKR2—Crohn's disease	0.00157	0.00194	CbGpPWpGaD
Pasireotide—Abdominal distension—Prednisone—Crohn's disease	0.00155	0.00872	CcSEcCtD
Pasireotide—Hypotension—Mesalazine—Crohn's disease	0.00155	0.0087	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00153	0.0019	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TAGAP—Crohn's disease	0.00153	0.0019	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00151	0.00848	CcSEcCtD
Pasireotide—Insomnia—Mesalazine—Crohn's disease	0.0015	0.00842	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—GPR65—Crohn's disease	0.0015	0.00185	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CCR6—Crohn's disease	0.00149	0.00185	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00149	0.00836	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—MLN—Crohn's disease	0.00149	0.00184	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.00147	0.00182	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ACKR2—Crohn's disease	0.00145	0.00179	CbGpPWpGaD
Pasireotide—Decreased appetite—Mesalazine—Crohn's disease	0.00144	0.00809	CcSEcCtD
Pasireotide—Abdominal pain—Azathioprine—Crohn's disease	0.00144	0.00808	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CCR6—Crohn's disease	0.00143	0.00177	CbGpPWpGaD
Pasireotide—Fatigue—Mesalazine—Crohn's disease	0.00143	0.00803	CcSEcCtD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00142	0.00176	CbGpPWpGaD
Pasireotide—Constipation—Mesalazine—Crohn's disease	0.00142	0.00796	CcSEcCtD
Pasireotide—SSTR3—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00141	0.00174	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RSPO3—Crohn's disease	0.0014	0.00173	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Prednisone—Crohn's disease	0.00139	0.00781	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—MLN—Crohn's disease	0.00137	0.0017	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TAGAP—Crohn's disease	0.00136	0.00168	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCR6—Crohn's disease	0.00136	0.00168	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00135	0.00761	CcSEcCtD
Pasireotide—SSTR1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00135	0.00167	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RSPO3—Crohn's disease	0.00134	0.00166	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SEL1L—Crohn's disease	0.00132	0.00164	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PTGER4—Crohn's disease	0.00132	0.00163	CbGpPWpGaD
Pasireotide—Abdominal pain—Mesalazine—Crohn's disease	0.00131	0.00736	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00131	0.00162	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.0013	0.00161	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCR6—Crohn's disease	0.0013	0.00161	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CCR6—Crohn's disease	0.00127	0.00157	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SEL1L—Crohn's disease	0.00127	0.00157	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00126	0.00156	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TAGAP—Crohn's disease	0.00125	0.00155	CbGpPWpGaD
Pasireotide—Diarrhoea—Azathioprine—Crohn's disease	0.00124	0.00699	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CCR9—Crohn's disease	0.00121	0.0015	CbGpPWpGaD
Pasireotide—Dizziness—Azathioprine—Crohn's disease	0.0012	0.00676	CcSEcCtD
Pasireotide—SSTR5—G alpha (i) signalling events—CXCL8—Crohn's disease	0.0012	0.00148	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PTGER4—Crohn's disease	0.0012	0.00148	CbGpPWpGaD
Pasireotide—Asthenia—Mesalazine—Crohn's disease	0.00119	0.00668	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—RSPO3—Crohn's disease	0.00119	0.00147	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CCR6—Crohn's disease	0.00117	0.00145	CbGpPWpGaD
Pasireotide—Pruritus—Mesalazine—Crohn's disease	0.00117	0.00659	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CCR9—Crohn's disease	0.00116	0.00144	CbGpPWpGaD
Pasireotide—Vomiting—Azathioprine—Crohn's disease	0.00116	0.0065	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CCR6—Crohn's disease	0.00115	0.00143	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PTGER4—Crohn's disease	0.00115	0.00142	CbGpPWpGaD
Pasireotide—Headache—Azathioprine—Crohn's disease	0.00114	0.0064	CcSEcCtD
Pasireotide—Diarrhoea—Mesalazine—Crohn's disease	0.00113	0.00637	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—SEL1L—Crohn's disease	0.00113	0.00139	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GPR65—Crohn's disease	0.00113	0.00139	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL3—Crohn's disease	0.00112	0.00139	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00112	0.00139	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PTGER4—Crohn's disease	0.00112	0.00139	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.0011	0.00137	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RSPO3—Crohn's disease	0.0011	0.00136	CbGpPWpGaD
Pasireotide—Dizziness—Mesalazine—Crohn's disease	0.0011	0.00616	CcSEcCtD
Pasireotide—Alopecia—Prednisone—Crohn's disease	0.00109	0.00613	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00108	0.00134	CbGpPWpGaD
Pasireotide—Nausea—Azathioprine—Crohn's disease	0.00108	0.00607	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—GPR65—Crohn's disease	0.00108	0.00134	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL3—Crohn's disease	0.00107	0.00133	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00107	0.00133	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00107	0.00132	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCR6—Crohn's disease	0.00107	0.00132	CbGpPWpGaD
Pasireotide—Vomiting—Mesalazine—Crohn's disease	0.00105	0.00592	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.00105	0.0013	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00104	0.00129	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SEL1L—Crohn's disease	0.00104	0.00129	CbGpPWpGaD
Pasireotide—Headache—Mesalazine—Crohn's disease	0.00104	0.00583	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00103	0.00128	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR9—Crohn's disease	0.00103	0.00127	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL3—Crohn's disease	0.00102	0.00126	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PTGER4—Crohn's disease	0.00102	0.00126	CbGpPWpGaD
Pasireotide—Anaemia—Prednisone—Crohn's disease	0.000993	0.00558	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000985	0.00122	CbGpPWpGaD
Pasireotide—Nausea—Mesalazine—Crohn's disease	0.000984	0.00553	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—IL3—Crohn's disease	0.000976	0.00121	CbGpPWpGaD
Pasireotide—Vertigo—Prednisone—Crohn's disease	0.000965	0.00542	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—GPR65—Crohn's disease	0.000957	0.00118	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL3—Crohn's disease	0.000953	0.00118	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000952	0.00118	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR9—Crohn's disease	0.00095	0.00118	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000944	0.00117	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PTGER4—Crohn's disease	0.000938	0.00116	CbGpPWpGaD
Pasireotide—Hypertension—Prednisone—Crohn's disease	0.000927	0.00521	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000922	0.00114	CbGpPWpGaD
Pasireotide—Myalgia—Prednisone—Crohn's disease	0.000914	0.00514	CcSEcCtD
Pasireotide—Arthralgia—Prednisone—Crohn's disease	0.000914	0.00514	CcSEcCtD
Pasireotide—Anxiety—Prednisone—Crohn's disease	0.000911	0.00512	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—GPR65—Crohn's disease	0.000883	0.00109	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL3—Crohn's disease	0.00088	0.00109	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000878	0.00109	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL3—Crohn's disease	0.000866	0.00107	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000861	0.00107	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CXCL8—Crohn's disease	0.000852	0.00106	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000851	0.00105	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—RASGRP1—Crohn's disease	0.000837	0.00104	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CXCL8—Crohn's disease	0.000817	0.00101	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCR6—Crohn's disease	0.000802	0.000993	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL3—Crohn's disease	0.000799	0.000989	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000799	0.00449	CcSEcCtD
Pasireotide—Insomnia—Prednisone—Crohn's disease	0.000793	0.00446	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000785	0.000972	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000773	0.000956	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR6—Crohn's disease	0.000769	0.000952	CbGpPWpGaD
Pasireotide—Decreased appetite—Prednisone—Crohn's disease	0.000762	0.00428	CcSEcCtD
Pasireotide—Fatigue—Prednisone—Crohn's disease	0.000756	0.00425	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000753	0.000932	CbGpPWpGaD
Pasireotide—Constipation—Prednisone—Crohn's disease	0.00075	0.00421	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—RBX1—Crohn's disease	0.000725	0.000898	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CXCL8—Crohn's disease	0.000725	0.000897	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000717	0.00403	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—IL2RA—Crohn's disease	0.000713	0.000883	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTGER4—Crohn's disease	0.000706	0.000874	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RBX1—Crohn's disease	0.000695	0.000861	CbGpPWpGaD
Pasireotide—Abdominal pain—Prednisone—Crohn's disease	0.000693	0.00389	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—IL2RA—Crohn's disease	0.000684	0.000846	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR6—Crohn's disease	0.000682	0.000844	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTGER4—Crohn's disease	0.000677	0.000838	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CXCL8—Crohn's disease	0.000669	0.000828	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2RA—Crohn's disease	0.000668	0.000827	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—UBE2D1—Crohn's disease	0.000636	0.000787	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR6—Crohn's disease	0.000629	0.000779	CbGpPWpGaD
Pasireotide—Asthenia—Prednisone—Crohn's disease	0.000629	0.00353	CcSEcCtD
Pasireotide—Pruritus—Prednisone—Crohn's disease	0.00062	0.00349	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—RIPK2—Crohn's disease	0.000617	0.000763	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RBX1—Crohn's disease	0.000617	0.000763	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000616	0.000763	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—UBE2D1—Crohn's disease	0.00061	0.000755	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2RA—Crohn's disease	0.000606	0.000751	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL3—Crohn's disease	0.000601	0.000744	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTGER4—Crohn's disease	0.0006	0.000743	CbGpPWpGaD
Pasireotide—Diarrhoea—Prednisone—Crohn's disease	0.0006	0.00337	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—RIPK2—Crohn's disease	0.000591	0.000732	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RASGRP1—Crohn's disease	0.000582	0.00072	CbGpPWpGaD
Pasireotide—Dizziness—Prednisone—Crohn's disease	0.00058	0.00326	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—IL3—Crohn's disease	0.000577	0.000714	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RBX1—Crohn's disease	0.000569	0.000704	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2RA—Crohn's disease	0.00056	0.000693	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RASGRP1—Crohn's disease	0.000558	0.00069	CbGpPWpGaD
Pasireotide—Vomiting—Prednisone—Crohn's disease	0.000557	0.00313	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—PTGER4—Crohn's disease	0.000554	0.000686	CbGpPWpGaD
Pasireotide—Headache—Prednisone—Crohn's disease	0.000549	0.00309	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—UBE2D1—Crohn's disease	0.000541	0.000669	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—JAK2—Crohn's disease	0.000528	0.000653	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SOCS1—Crohn's disease	0.000527	0.000652	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RIPK2—Crohn's disease	0.000524	0.000649	CbGpPWpGaD
Pasireotide—Nausea—Prednisone—Crohn's disease	0.000521	0.00293	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—IL3—Crohn's disease	0.000511	0.000633	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—JAK2—Crohn's disease	0.000506	0.000626	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SOCS1—Crohn's disease	0.000505	0.000625	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TYK2—Crohn's disease	0.000502	0.000622	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—UBE2D1—Crohn's disease	0.000499	0.000618	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RASGRP1—Crohn's disease	0.000495	0.000612	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RIPK2—Crohn's disease	0.000484	0.000599	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000482	0.000596	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TYK2—Crohn's disease	0.000482	0.000596	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—JAK2—Crohn's disease	0.000479	0.000593	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL3—Crohn's disease	0.000472	0.000584	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000462	0.000572	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—JAK2—Crohn's disease	0.00046	0.000569	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RASGRP1—Crohn's disease	0.000456	0.000565	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SMAD3—Crohn's disease	0.000455	0.000563	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—JAK2—Crohn's disease	0.000449	0.000556	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SOCS1—Crohn's disease	0.000448	0.000555	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCL8—Crohn's disease	0.000437	0.000542	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SMAD3—Crohn's disease	0.000436	0.00054	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TYK2—Crohn's disease	0.000427	0.000529	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2RA—Crohn's disease	0.000421	0.000521	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCL8—Crohn's disease	0.000419	0.000519	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—JAK2—Crohn's disease	0.000414	0.000513	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SOCS1—Crohn's disease	0.000414	0.000512	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL8—Crohn's disease	0.00041	0.000507	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—JAK2—Crohn's disease	0.000408	0.000504	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2RA—Crohn's disease	0.000404	0.0005	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TYK2—Crohn's disease	0.000394	0.000488	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SMAD3—Crohn's disease	0.000387	0.000479	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000378	0.000468	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—JAK2—Crohn's disease	0.000376	0.000466	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL8—Crohn's disease	0.000372	0.00046	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2RA—Crohn's disease	0.000358	0.000443	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SMAD3—Crohn's disease	0.000357	0.000442	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL8—Crohn's disease	0.000343	0.000425	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2RA—Crohn's disease	0.000331	0.000409	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TYK2—Crohn's disease	0.000297	0.000367	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TYK2—Crohn's disease	0.000285	0.000352	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JAK2—Crohn's disease	0.000283	0.00035	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JAK2—Crohn's disease	0.000271	0.000336	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL8—Crohn's disease	0.000258	0.00032	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TYK2—Crohn's disease	0.000252	0.000312	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL8—Crohn's disease	0.000248	0.000307	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—Crohn's disease	0.000246	0.000304	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JAK2—Crohn's disease	0.000241	0.000298	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—Crohn's disease	0.000236	0.000292	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TYK2—Crohn's disease	0.000233	0.000288	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JAK2—Crohn's disease	0.000222	0.000275	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL8—Crohn's disease	0.00022	0.000272	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—Crohn's disease	0.000209	0.000259	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—Crohn's disease	0.000208	0.000257	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL8—Crohn's disease	0.000203	0.000251	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—Crohn's disease	0.000199	0.000247	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—Crohn's disease	0.000193	0.000239	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—Crohn's disease	0.000177	0.000219	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—Crohn's disease	0.000163	0.000202	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—Crohn's disease	0.000145	0.00018	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—Crohn's disease	0.000139	0.000172	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—Crohn's disease	0.000123	0.000153	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—Crohn's disease	0.000114	0.000141	CbGpPWpGaD
